Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Myelodysplastic Syndromes 1Leukemia 1Hematologic Neoplasms 1Bone Marrow Failure Disorders 1Anemia, Aplastic 1Anemia 1

Interventions

Standard of Care 9Exercise 9Educational Status 8Practice Guidelines as Topic 7Methods 7Blood Specimen Collection 7Early Intervention, Educational 6Palliative Care 5Interviews as Topic 5Behavior Therapy 5fludarabine 4Surveys and Questionnaires 4Physical Therapy Modalities 4Cyclophosphamide 4Magnetic Resonance Spectroscopy 3Health Promotion 3Granulocyte Colony-Stimulating Factor 3pegylated granulocyte colony-stimulating factor 2fludarabine phosphate 2Whole-Body Irradiation 2Therapeutic Touch 2Stem Cell Transplantation 2Restraint, Physical 2Radiosurgery 2Patient Navigation 2Parenteral Nutrition 2Low-Level Light Therapy 2Etoposide 2Cytarabine 2Control Groups 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Hematologic Neoplasms × Blood Component Transfusion × Clear all
NCT03086252 2018-07-26

Patient-Driven Transfusion Thresholds in Hematological Disorders: A Pilot Study

Emory University

Phase NA Withdrawn
Classical hematologyMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Anemia, Aplastic, Leukemia, Myelodysplastic Syndromes, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡